oncohost
ConnectOncoHost is a technology company headquartered in Binyamina, Israel, and Cary, North Carolina, transforming the approach to precision medicine for improved patient outcomes.
OncoHost’s proprietary platform, PROphet®️, is a plasma-based, proteomic pattern analysis tool whose initial offering in non-small cell lung cancer (NSCLC) uses a single blood sample to guide first-line immunotherapy decision-making. The PROphet®️ NSCLC test provides clear clinical utility by offering physicians crucial guidance on the optimal first-line immunotherapy treatment plan for each individual patient, with a significant effect on overall survival.
The company is led by an experienced team of entrepreneurs and industry experts and supported by large-scale prospective clinical trial.
Connect With oncohost
Dr. Ofer Sharon
CEO
Ofer Sharon, MD is the CEO of OncoHost a commercial stage precision oncology company combining blood based proteomic analysis and AI. to provide clinicians with combinations strategies to overcome treatment resistance and improve patient outcomes. Dr. Sharon is a physician and serial entrepreneur over 20 years of experience in clinical and commercial product development. Ofer is the co-founder of Valera Health a commercial stage US company. He served multiple roles in global pharmaceutical companies including Medical Director for AstraZeneca and Medimmune and Medical Director for MSD.
Connect